|
ZNF302 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.221000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.002200E-01 |
| Normal-vs-Stage2 |
8.444400E-01 |
| Normal-vs-Stage3 |
8.267800E-01 |
| Normal-vs-Stage4 |
2.464800E-01 |
| Stage1-vs-Stage2 |
9.999800E-01 |
| Stage1-vs-Stage3 |
6.844200E-01 |
| Stage1-vs-Stage4 |
5.270200E-01 |
| Stage2-vs-Stage3 |
7.604800E-01 |
| Stage2-vs-Stage4 |
5.930000E-01 |
| Stage3-vs-Stage4 |
3.614400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.984800E-01 |
| Normal-vs-AfricanAmerican |
9.126600E-01 |
| Normal-vs-Asian |
3.374800E-01 |
| Caucasian-vs-AfricanAmerican |
9.898400E-01 |
| Caucasian-vs-Asian |
1.362410E-01 |
| AfricanAmerican-vs-Asian |
1.899970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.845600E-01 |
| Normal-vs-Female |
9.694000E-01 |
| Male-vs-Female |
8.625600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.289800E-01 |
| Normal-vs-Extreme_Weight |
6.264800E-01 |
| Normal-vs-Obese |
7.687400E-01 |
| Normal-vs-Extreme_Obese |
8.281400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.422400E-01 |
| Normal_Weight-vs-Obese |
8.721200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.451000E-01 |
| Extreme_Weight-vs-Obese |
4.880400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.360800E-01 |
| Obese-vs-Extreme_Obese |
7.702400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.797600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.220800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.232400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.789600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.367200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.555000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.221400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.314000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.034400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.186400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.307000E-01 |
| Normal-VS-Type2 PRCC |
1.593020E-01 |
| Normal-VS-KIRP CIMP |
1.145030E-01 |
| Normal-VS-Unclassified PRCC |
9.728200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.568260E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.801500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.137200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.003800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.772200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.651200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.194400E-01 |
| Normal-vs-N1 |
5.773000E-01 |
| Normal-vs-N2 |
3.579200E-04 |
| N0-vs-N1 |
4.962800E-01 |
| N0-vs-N2 |
7.153800E-02 |
| N1-vs-N2 |
9.280000E-03 |
|
|
